The gap between what research costs and what grants cover keeps widening
Australia's independent research institutes are caught in a slow fiscal erosion — not a sudden collapse, but a decade-long drift in which the cost of doing science has quietly outpaced the public investment meant to sustain it. With real funding growth averaging just 1.4 percent annually, the country risks losing not only its laboratories' momentum but the early-career researchers who represent its scientific future. A new national strategy proposes structural remedies, but the deeper question is whether democratic institutions can act with the urgency that slow-moving crises rarely seem to demand.
- Indirect research costs now routinely exceed the block grants designed to cover them, leaving institutes to quietly absorb deficits year after year with no margin for error.
- Grant success rates are falling, and the pressure lands hardest on early- and mid-career scientists who are leaving the field rather than endure the compounding uncertainty.
- Two major Commonwealth funding vehicles — the Medical Research Endowment Account and the Medical Research Future Fund — operate in separate silos, creating duplication and strategic blind spots no single institute can fix alone.
- Australia's first National Health and Medical Research Strategy proposes a unified oversight agency, a dedicated high-risk discovery stream, and standardized indirect cost support to begin closing the structural gap.
- The strategy now awaits government action, and the institutes are clear: without intervention, talent and momentum will continue migrating to countries that fund their scientists more generously.
Australia's independent research institutes are not facing a sudden crisis — they are facing a slow one, which in many ways is harder to stop. Over the past decade, real funding growth for health and medical research has averaged just 1.4 percent annually, barely keeping pace with inflation and falling well short of the actual cost curve of modern science. The federal government funds roughly 77 percent of the country's $5.3 billion annual health research spend, but the trajectory of that investment has quietly undermined the system it was meant to sustain.
The human cost is most visible among early- and mid-career researchers. As grant success rates decline, these scientists — the ones who should be building Australia's next generation of discoveries — face mounting job insecurity and are leaving the field entirely. The country is losing the researchers it most needs precisely when it can least afford to.
Structurally, the problem has two roots. Indirect research costs consistently exceed the block grants meant to cover them, and the two major Commonwealth funding vehicles operate in separate silos with little coordination, producing inefficiencies and gaps that no single institute can bridge.
Australia's first-ever National Health and Medical Research Strategy, covering 2026 to 2036, proposes three responses: a dedicated stream for high-risk, high-reward discovery research using a fail-fast model; standardized indirect cost support across both major funding vehicles; and a unified executive agency to oversee both funds under coordinated but distinct governance.
The strategy now moves into government consideration. The institutes have stated their case plainly — without meaningful intervention, Australia's research system will continue to hollow out, ceding ground to nations willing to invest more generously in their scientists.
Australia's independent research institutes are running out of money. Not dramatically, not all at once—but steadily, year after year, in a way that leaves no room for error. The gap between what it costs to do research and what the government provides to cover those costs keeps widening, and the institutes are warning that the system is approaching a breaking point.
The numbers tell the story. In the 2023-24 financial year, Australia spent roughly $5.3 billion on health and medical research. The federal government picked up the largest share at $4.1 billion, or about 77 percent of the total. State and territory governments added another $839 million, and the non-government sector contributed $419 million. On paper, that looks substantial. But look at the trajectory over the past decade, and the picture darkens. Real funding growth—the kind that actually keeps pace with inflation and the rising cost of doing science—averaged just 1.4 percent annually. That's barely above the inflation line and nowhere near the speed at which research costs have climbed.
This mismatch has real consequences for real people. Grant success rates are falling, which means researchers are competing harder for smaller slices of the pie. The pressure falls heaviest on early- and mid-career scientists—the cohort that should be building the foundation for Australia's next generation of discoveries. Instead, many are facing job insecurity and leaving the field entirely. The country is losing the researchers it most needs to replace the ones retiring.
The problem sits at the intersection of two structural issues. First, the indirect costs of research—the overhead, the facilities, the administrative machinery that makes labs run—keep exceeding the block grants meant to cover them. Second, Australia's major research funding vehicles, the Medical Research Endowment Account and the Medical Research Future Fund, operate in separate silos with limited coordination. This creates inefficiencies, duplication, and gaps that no single institute can bridge alone.
The Department of Health, Disability and Ageing released Australia's first-ever National Health and Medical Research Strategy covering 2026 to 2036, and it proposes three main fixes. The first is a new dedicated funding stream for high-risk, high-reward discovery research—the kind of work that might fail but could also transform the field. This stream would use a fail-fast approach with short timeframes and targeted budgets, allowing researchers to take bigger swings without betting their careers on every grant application.
The second proposal is to standardize how indirect research costs are supported across both major funding vehicles, with an initial boost to the Medical Research Future Fund grants to help close the gap immediately.
The third is structural. A unified executive agency would oversee both the Endowment Account and the Future Fund, with coordinated but separate governance to preserve each fund's distinct purpose. This would eliminate the current fragmentation and create a single strategic view of where research dollars are going and where they're needed most.
None of this is guaranteed. The strategy now moves into government consideration, with implementation planned in phases. But the institutes have made their case clear: without intervention, Australia's research system will continue to hollow out, losing talent and momentum to countries that fund their scientists more generously. The question is whether the government will act before the damage becomes irreversible.
Citações Notáveis
Independent research institutes are warning that they are becoming financially unsustainable as indirect costs continue to outstrip block grants— Australia's National Health and Medical Research Strategy 2026-2036
A Conversa do Hearth Outra perspectiva sobre a história
Why does a 1.4% funding increase feel like a crisis? Isn't that still growth?
Because inflation alone eats most of it. Modern research—equipment, salaries, facilities—costs more each year. When your budget barely keeps up with inflation, you're actually losing ground in real terms. You can do less with the same money.
So the institutes are being squeezed from both sides?
Exactly. The block grants aren't growing fast enough to cover the indirect costs that keep rising. It's like your mortgage payment stays the same while property taxes and utilities climb every year. Eventually something has to give.
And the researchers leaving—is that the real danger here?
It is. Early-career scientists are the pipeline. If they can't get grants, can't secure jobs, they leave for other countries or other fields. You lose a generation of talent, and you can't just rebuild that overnight. It compounds.
The strategy proposes three things. Which one actually solves the problem?
Honestly, probably none of them alone. The fail-fast funding stream helps risk-taking. The indirect cost support helps immediately. But the unified agency is the structural fix—it stops the duplication and fragmentation that wastes money. You need all three working together.
What happens if the government doesn't act?
The institutes keep bleeding researchers. Grant success rates keep falling. The best scientists migrate elsewhere. Australia's research output declines relative to competitors. It's not a sudden collapse—it's a slow fade that's hard to reverse once it starts.